ABEONA THERAPEUTICS INC. Gain (Loss) on Fair Value Hedges Recognized in Earnings
ABEONA THERAPEUTICS INC. (ABEO) reported Gain (Loss) on Fair Value Hedges Recognized in Earnings of $7.46 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings · last filed 2023-11-13
- ABEONA THERAPEUTICS INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2023-09-30 was $1.10M.
| Period end | Gain (Loss) on Fair Value Hedges Recognized in Earnings 3 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 6 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 9 month |
|---|---|---|---|
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $7.46M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $6.36M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |